The pK(a) Distribution of Drugs: Application to Drug Discovery
- PMID: 19812734
- PMCID: PMC2754920
The pK(a) Distribution of Drugs: Application to Drug Discovery
Abstract
The acid-base dissociation constant (pK(a)) of a drug is a key physicochemical parameter influencing many biopharmaceutical characteristics. While this has been well established, the overall proportion of non-ionizable and ionizable compounds for drug-like substances is not well known. Even less well known is the overall distribution of acid and base pK(a) values. The current study has reviewed the literature with regard to both the proportion of ionizable substances and pK(a) distributions. Further to this a set of 582 drugs with associated pK(a) data was thoroughly examined to provide a representative set of observations. This was further enhanced by delineating the compounds into CNS and non-CNS drugs to investigate where differences exist. Interestingly, the distribution of pK(a) values for single acids differed remarkably between CNS and non-CNS substances with only one CNS compound having an acid pK(a) below 6.1. The distribution of basic substances in the CNS set also showed a marked cut off with no compounds having a pK(a) above 10.5.The pK(a) distributions of drugs are influenced by two main drivers. The first is related to the nature and frequency of occurrence of the functional groups that are commonly observed in pharmaceuticals and the typical range of pK(a) values they span. The other factor concerns the biological targets these compounds are designed to hit. For example, many CNS targets are based on seven transmembrane G protein-coupled receptors (7TM GPCR) which have a key aspartic acid residue known to interact with most ligands. As a consequence, amines are mostly present in the ligands that target 7TM GPCR's and this influences the pK(a) profile of drugs containing basic groups. For larger screening collections of compounds, synthetic chemistry and the working practices of the chemists themselves can influence the proportion of ionizable compounds and consequent pK(a) distributions. The findings from this study expand on current wisdom in pK(a) research and have implications for discovery research with regard to the composition of corporate databases and collections of screening compounds. Rough guidelines have been suggested for the profile of compound collections and will evolve as this research area is expanded.
Keywords: ADME; absorption; acids; ampholytes; bases; bioavailability; dissociation constant; distribution; drug discovery; drugs; pKa; pharmacokinetics.
Figures
Similar articles
-
The acid-base profile of a contemporary set of drugs: implications for drug discovery.SAR QSAR Environ Res. 2009 Oct;20(7-8):611-55. doi: 10.1080/10629360903438313. SAR QSAR Environ Res. 2009. PMID: 20024802
-
A chemogenomic analysis of ionization constants--implications for drug discovery.ChemMedChem. 2013 Feb;8(2):242-55. doi: 10.1002/cmdc.201200507. Epub 2013 Jan 9. ChemMedChem. 2013. PMID: 23303535 Free PMC article.
-
Analysis of the Acid/Base Profile of Natural Products from Different Sources.Mol Inform. 2020 Mar;39(3):e1900099. doi: 10.1002/minf.201900099. Epub 2019 Sep 26. Mol Inform. 2020. PMID: 31556481
-
Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.Curr Drug Metab. 2006 Feb;7(2):165-82. doi: 10.2174/138920006775541552. Curr Drug Metab. 2006. PMID: 16472106 Review.
-
Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.Chem Biodivers. 2009 Nov;6(11):2030-49. doi: 10.1002/cbdv.200900103. Chem Biodivers. 2009. PMID: 19937839 Review.
Cited by
-
In silico analysis of luteolin derivatives as antibacterial agents targeting DNA gyrase and CTX-M-15 extended-spectrum β-lactamase of Escherichia coli.J Adv Pharm Technol Res. 2024 Jan-Mar;15(1):29-36. doi: 10.4103/JAPTR.JAPTR_217_23. Epub 2024 Jan 15. J Adv Pharm Technol Res. 2024. PMID: 38389968 Free PMC article.
-
Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.J Transl Med. 2024 Feb 16;22(1):167. doi: 10.1186/s12967-024-04908-2. J Transl Med. 2024. PMID: 38365798 Free PMC article. Review.
-
Chemical Space Covered by Applicability Domains of Quantitative Structure-Property Relationships and Semiempirical Relationships in Chemical Assessments.Environ Sci Technol. 2024 Jan 23;58(7):3386-98. doi: 10.1021/acs.est.3c05643. Online ahead of print. Environ Sci Technol. 2024. PMID: 38263624 Free PMC article.
-
Acidic pH modulates Burkholderia cenocepacia antimicrobial susceptibility in the cystic fibrosis nutritional environment.Microbiol Spectr. 2023 Dec 12;11(6):e0273123. doi: 10.1128/spectrum.02731-23. Epub 2023 Nov 15. Microbiol Spectr. 2023. PMID: 37966209 Free PMC article.
-
Flavonoids in the Spotlight: Bridging the Gap between Physicochemical Properties and Formulation Strategies.Pharmaceuticals (Basel). 2023 Oct 3;16(10):1407. doi: 10.3390/ph16101407. Pharmaceuticals (Basel). 2023. PMID: 37895878 Free PMC article. Review.
References
-
- Kerns EH, Di L. Physicochemical profiling: overview of the screens. Drug Discov Today: Technologies. 2004;1:343–8. - PubMed
-
- Avdeef A. Physicochemical profiling (solubility, permeability and charge state) Curr. Top. Med. Chem. 2001;1:277–351. - PubMed
-
- Xie X, Steiner SH, Bickel MH. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. II. Benzodiazepines. Drug Metab. Dispos. 1991;19:15–9. - PubMed
-
- Jones T, Taylor G. Quantitative structure-pharmacokinetic relationships amongst phenothiazine drugs. Proc. - Eur. Congr. Biopharm. Pharmacokinet. 3rd. 1987;2:181–90.
-
- Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin. Pharmacokinet. 1987;12:253–91. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials